| 亞洲大學 |
2018-05 |
Digoxin and Amiodarone on the Risk of Ischemic Stroke in Atrial Fibrillation: An Observational Study.
|
Kuan-Cheng, L;Lai, Kuan-Cheng;Chen, Sy-Jou;Chen, Sy-Jou;Chin-Sheng, L;Lin, Chin-Sheng;Yang, Fu-Chi;Yang, Fu-Chi;Lin, Cheng-Li;Lin, Cheng-Li;Hs, Chin-Wang;Hsu, Chin-Wang;Hua, Wen-Chen;Huang, Wen-Chen;高嘉鴻;Kao, Chia-Hung;* |
| 臺北醫學大學 |
2012-07-02 |
Digoxin Associates with Mortality in End-Stage Renal Disease Patients Receiving Hemodialysis
|
Wu, Lu-Hsuan; 吳律萱 |
| 中國醫藥大學 |
2004-11? |
DIGOXIN INTOXICATION?
|
賴沛均; 蔡輝彥? |
| 大葉大學 |
2015-05 |
Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer.
|
Lin, Sheng-Yi;Chang, Hsiu-Hui;Lai, Yi-Hua;Lin, Ching-Hsiung;Chen, Min-Hsuan;Chang, Gee-Chen;Tsai, Meng-Feng;Chen, Jeremy J. W. |
| 中國醫藥大學 |
2015-02 |
Digoxin use may increase the relative risk of acute pancreatitis: A population-based case-control study in Taiwan
|
賴世偉(Shih-Wei Lai);林橙莉;廖光福(Kuan-Fu Liao)* |
| 臺北醫學大學 |
2014 |
Digoxin(毛地黃)藥物服用護理指導
|
心臟內科 |
| 國立臺灣大學 |
2016 |
Digoxin-amiodarone combination is associated with excess all-cause mortality in patients with atrial fibrillation
|
Chiang, J. -Y.; Lin, L. Y.; Chen, P. C.; Yang, Y. H.; Chen, J. J.; Wu, C. K.; Hwang, J. J.; Lin, J. L.; Chiang, T.; 林亮宇; 陳保中; 林俊立; 吳卓鍇; 陳建鈞; 楊曜旭; 黃瑞仁; 陳錦澤 |
| 臺大學術典藏 |
2018-09-10T15:37:53Z |
Digoxin-amiodarone combination is associated with excess all-cause mortality in patients with atrial fibrillation
|
Chiang, J. Y. ; Lin, L. Y. ; Chen, P. C. ; Yang, Y. H. ; Chen, J. J. ; Wu, C. K. ; Hwang, J. J. ; Lin, J. L. ; Chiang, T.; Pau-Chung CHEN |
| 臺大學術典藏 |
2020-05-15T07:08:22Z |
Digoxin-amiodarone Combination is Associated With Excess All-cause Mortality in Patients With Atrial Fibrillation
|
Pau-Chung Chen;Lin J.-L.;Lin L.-Y.;Chiang F.-T.;Hwang J.-J.;Wu C.-K.;Chen J.-J.;Chu F.-Y.;Chang C.-H.;Yang Y.-H.;Chiang J.-Y.; Pau-Chung CHEN; TA-CHEN SU; KUO-LIONG CHIEN |
| 臺大學術典藏 |
2020-12-04T07:44:27Z |
Digoxin-amiodarone Combination is Associated With Excess All-cause Mortality in Patients With Atrial Fibrillation
|
Chiang J.-Y.; Chen P.-C.; Yang Y.-H.; Chang C.-H.; Chu F.-Y.; Chen J.-J.; Wu C.-K.; Hwang J.-J.; Chiang F.-T.; LIAN-YU LIN; Lin J.-L. |
| 臺大學術典藏 |
2021-03-11T04:29:12Z |
Digoxin-amiodarone Combination is Associated With Excess All-cause Mortality in Patients With Atrial Fibrillation
|
Chiang J.-Y.; Chen P.-C.; Yang Y.-H.; Chang C.-H.; Chu F.-Y.; Chen J.-J.; Wu C.-K.; Hwang J.-J.; FU-TIEN CHIANG; Lin L.-Y.; Lin J.-L. |
| 臺大學術典藏 |
2020-12-28T12:03:14Z |
Digoxin-amiodarone Combination is Associated With Excess All-cause Mortality in Patients With Atrial Fibrillation
|
Chiang J.-Y.; Chen P.-C.; Yang Y.-H.; Chang C.-H.; Chu F.-Y.; Chen J.-J.; Wu C.-K.; HWANG, JUEY-JEN; Chiang F.-T.; Lin L.-Y.; Lin J.-L. |
| 臺大學術典藏 |
2022-02-15T03:21:41Z |
Digoxin-amiodarone Combination is Associated With Excess All-cause Mortality in Patients With Atrial Fibrillation
|
Chiang J.-Y.; Chen P.-C.; Yang Y.-H.; Chang C.-H.; Chu F.-Y.; JIEN-JIUN CHEN; Wu C.-K.; Hwang J.-J.; Chiang F.-T.; Lin L.-Y.; Lin J.-L. |
| 臺大學術典藏 |
2022-03-31T02:38:24Z |
Digoxin-amiodarone Combination is Associated With Excess All-cause Mortality in Patients With Atrial Fibrillation
|
Chiang J.-Y.; PAU-CHUNG CHEN; Yang Y.-H.; Chang C.-H.; Chu F.-Y.; Chen J.-J.; Wu C.-K.; Hwang J.-J.; Chiang F.-T.; Lin L.-Y.; Lin J.-L. |
| 臺大學術典藏 |
2020-12-02T11:04:23Z |
Digoxin-amiodarone Combination is Associated With Excess All-cause Mortality in Patients With Atrial Fibrillation
|
Chiang J.-Y.; Chen P.-C.; Yang Y.-H.; Chang C.-H.; Chu F.-Y.; Chen J.-J.; CHO-KAI WU; Hwang J.-J.; Chiang F.-T.; Lin L.-Y.; Lin J.-L. |
| 臺大學術典藏 |
2022-09-06T02:41:45Z |
Digoxin-amiodarone Combination is Associated With Excess All-cause Mortality in Patients With Atrial Fibrillation
|
Chiang J.-Y.; Chen P.-C.; Yang Y.-H.; Chang C.-H.; Chu F.-Y.; Chen J.-J.; Wu C.-K.; Hwang J.-J.; Chiang F.-T.; LIAN-YU LIN; Lin J.-L. |
| 臺大學術典藏 |
2022-09-20T06:48:29Z |
Digoxin-amiodarone Combination is Associated With Excess All-cause Mortality in Patients With Atrial Fibrillation
|
Chiang J.-Y.; Chen P.-C.; Yang Y.-H.; Chang C.-H.; Chu F.-Y.; Chen J.-J.; Wu C.-K.; HWANG, JUEY-JEN; Chiang F.-T.; Lin L.-Y.; Lin J.-L. |
| 國立臺灣大學 |
1986 |
Digoxinn-Like Immunoreactive Substances in Cord and Neonatal Blood
|
Wu, C. H.; Chen, C. S.; 沈慶村; Wu, C. H.; Chen, C. S.; Shen, C. T. |
| 高雄醫學大學 |
2002 |
Digoxin可能為一種有效的抗癌藥物 --- 病例報告
|
江豐裕 |
| 臺北醫學大學 |
2015-12 |
Digoxin與其他藥物的交互作用
|
B313102157 |
| 高雄醫學大學 |
2005 |
Digoxin血中有效治療濃度範圍之評估
|
許綺娟; Hsu, Chi-Chang |
| 高雄醫學大學 |
2003 |
DIHB-TTDA及TTDA-BOM配位子及其金屬錯合物之合成、物性及化性研究
|
蔡素卿; Tsai, Su-Ching |
| 臺大學術典藏 |
2021-06-02T05:43:22Z |
Dihydroartemisinin–Bile Acid Hybridization as an Effective Approach to Enhance Dihydroartemisinin Anticancer Activity
|
Marchesi E.;Chinaglia N.;Capobianco M.L.;Marchetti P.;Huang T.-E.;Weng H.-C.;Jih-Hwa Guh;Hsu L.-C.;Perrone D.;Navacchia M.L.; Marchesi E.; Chinaglia N.; Capobianco M.L.; Marchetti P.; Huang T.-E.; Weng H.-C.; JIH-HWA GUH; Hsu L.-C.; Perrone D.; Navacchia M.L. |
| 臺大學術典藏 |
2021-07-06T07:01:15Z |
Dihydroartemisinin–Bile Acid Hybridization as an Effective Approach to Enhance Dihydroartemisinin Anticancer Activity
|
Marchesi E.;Chinaglia N.;Capobianco M.L.;Marchetti P.;Huang T.-E.;Weng H.-C.;Guh J.-H.;Lih-Ching Hsu;Perrone D.;Navacchia M.L.; Marchesi E.; Chinaglia N.; Capobianco M.L.; Marchetti P.; Huang T.-E.; Weng H.-C.; Guh J.-H.; LIH-CHING HSU; Perrone D.; Navacchia M.L. |
| 中國醫藥大學 |
2015-05 |
Dihydroaustrasulfone Alcohol (WA-25) Impedes Macrophage Foam Cell Formation by Regulating the Transforming Growth Factor-beta 1 Pathway
|
(Wang, Yi-Chen);(Hung, Han-Chun);(Feng, Chien-Wei);(Huang, Shi-Ying);(Chen, Chun-Hong);(Sheu, Jyh-Horng)*;許志宏(Jyh-Horng Sheu)* |
